{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T23:08:50Z","timestamp":1794956930772,"version":"4.9.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T00:00:00Z","timestamp":1674777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T00:00:00Z","timestamp":1674777600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>The study of molecular mechanisms characterizing disease progression may be relevant to get insights into systemic sclerosis (SSc) pathogenesis and to intercept patients at very early stage. We aimed at investigating the proteomic profile of preclinical systemic sclerosis (PreSSc) via a discovery\/validation two-step approach.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>SOMAcan aptamer-based analysis was performed on a serum sample of 13 PreSSc (discovery cohort) according to 2001 LeRoy and Medsger criteria (characterized solely by Raynaud phenomenon plus a positive nailfold capillaroscopy and SSc-specific antibodies without any other sign of definite disease) and 8 healthy controls (HCs) age, gender, and ethnicity matched. Prospective data were available up to 4\u00b10.6 years to determine the progression to definite SSc according to the EULAR\/ACR 2013 classification criteria. In proteins with relative fluorescence units (RFU) &gt; |1.5|-fold vs HCs values, univariate analysis was conducted via bootstrap aggregating models to determine the predicting accuracy (progression vs non-progression) of categorized baseline protein values. Gene Ontologies (GO terms) and Reactome terms of significant proteins at the adjusted 0.05 threshold were explored. Significant proteins from the discovery cohort were finally validated via ELISAs in an independent validation cohort of 50 PreSSc with clinical prospective data up to 5 years. Time-to-event analysis for interval-censored data was used to evaluate disease progression.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In the discovery cohort, 286 out of 1306 proteins analyzed via SomaScan, were differentially expressed versus HCs. Ten proteins were significantly associated with disease progression; analysis through GO and Reactome showed differentially enriched pathways involving angiogenesis, endothelial cell chemotaxis, and endothelial cell chemotaxis to fibroblast growth factor (FGF). In the validation cohort, endostatin (HR=10.23, CI95=2.2\u201347.59,<jats:italic>p<\/jats:italic>=0.003) was strongly associated with disease progression, as well as bFGF (HR=0.84, CI95=0.709-0.996,<jats:italic>p<\/jats:italic>=0.045) and PAF-AH\u03b2 (HR=0.372, CI95=0.171\u20130.809,<jats:italic>p<\/jats:italic>=0.013)<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>A distinct protein profile characterized PreSSc from HCs and proteins associated with hypoxia, vasculopathy, and fibrosis regulation are linked with the progression from preclinical to definite SSc. These proteins, in particular endostatin, can be regarded both as markers of severity and molecules with pathogenetic significance as well as therapeutic targets.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13075-023-02989-w","type":"journal-article","created":{"date-parts":[[2023,1,27]],"date-time":"2023-01-27T11:02:58Z","timestamp":1674817378000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Proteomic aptamer analysis reveals serum markers that characterize preclinical systemic sclerosis (SSc) patients at risk for progression toward definite SSc"],"prefix":"10.1186","volume":"25","author":[{"given":"Chiara","family":"Bellocchi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shervin","family":"Assassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marka","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Marchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Santaniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Beretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,27]]},"reference":[{"key":"2989_CR1","doi-asserted-by":"publisher","first-page":"137","DOI":"10.5301\/jsrd.5000249","volume":"2","author":"J Varga","year":"2017","unstructured":"Varga J, Trojanowska M, Kuwana M. Pathogenesis of systemic sclerosis: recent insights of molecular and cellular mechanisms and therapeutic opportunities. J Scleroderma Relat Disord. 2017;2:137\u201352 Available from: http:\/\/journals.sagepub.com\/doi\/10.5301\/jsrd.5000249.","journal-title":"J Scleroderma Relat Disord"},{"key":"2989_CR2","first-page":"1573","volume":"28","author":"EC LeRoy","year":"2001","unstructured":"LeRoy EC, Medsger TA. Criteria for the classification of early systemic sclerosis. J Rheumatol [Internet]. 2001;28:1573\u20136 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/11469464.","journal-title":"J Rheumatol [Internet]."},{"key":"2989_CR3","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 Classification Criteria for Systemic Sclerosis: An American College of Rheumatology\/European League Against Rheumatism Collaborative Initiative. Arthritis Rheum [Internet]. 2013;65:2737\u201347 Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.38098.","journal-title":"Arthritis Rheum [Internet]."},{"key":"2989_CR4","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1002\/art.24038","volume":"58","author":"M Koenig","year":"2008","unstructured":"Koenig M, Joyal F, Fritzler MJ, Roussin A, Abrahamowicz M, Boire G, et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud\u2019s phenomenon to systemic sclerosis: A twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosi. Arthritis Rheum. 2008;58:3902\u201312 Available from: https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.24038.","journal-title":"Arthritis Rheum"},{"key":"2989_CR5","doi-asserted-by":"publisher","first-page":"e834","DOI":"10.1016\/S2665-9913(21)00244-7","volume":"3","author":"S Bellando-Randone","year":"2021","unstructured":"Bellando-Randone S, Del Galdo F, Lepri G, Minier T, Huscher D, Furst DE, et al. Progression of patients with Raynaud\u2019s phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS). Lancet Rheumatol. 2021;3:e834\u201343 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2665991321002447.","journal-title":"Lancet Rheumatol"},{"key":"2989_CR6","doi-asserted-by":"crossref","unstructured":"Bellocchi C, Ying J, Goldmuntz EA, Keyes-Elstein L, Varga J, Hinchcliff ME, et al. Large-Scale Characterization of Systemic Sclerosis Serum Protein Profile: Comparison to Peripheral Blood Cell Transcriptome and Correlations With Skin\/Lung Fibrosis. Arthritis Rheumatol (Hoboken, NJ), Available from. 2021;73:660\u201370 http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33131208.","DOI":"10.1002\/art.41570"},{"key":"2989_CR7","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jid.2016.08.027","volume":"137","author":"LM Rice","year":"2017","unstructured":"Rice LM, Mantero JC, Stifano G, Ziemek J, Simms RW, Gordon J, et al. A Proteome-Derived Longitudinal Pharmacodynamic Biomarker for Diffuse Systemic Sclerosis Skin. J Invest Dermatol. 2017;137:62\u201370 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27640094.","journal-title":"J Invest Dermatol"},{"key":"2989_CR8","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1186\/s13075-021-02633-5","volume":"23","author":"V Farutin","year":"2021","unstructured":"Farutin V, Kurtagic E, Pradines JR, Capila I, Mayes MD, Wu M, et al. Multiomic study of skin, peripheral blood, and serum: is serum proteome a reflection of disease process at the end-organ level in systemic sclerosis? Arthritis Res Ther. 2021;23:259 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34654463.","journal-title":"Arthritis Res Ther"},{"key":"2989_CR9","unstructured":"Bandinelli F, Del Rosso A, Gabrielli A, Giacomelli R, Bartoli F, Guiducci S, et al. CCL2, CCL3 and CCL5 chemokines in systemic sclerosis: the correlation with SSc clinical features and the effect of prostaglandin E1 treatment. Clin Exp Rheumatol. 30:S44\u20139 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22691208."},{"key":"2989_CR10","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1093\/rheumatology\/kew017","volume":"55","author":"M Cossu","year":"2016","unstructured":"Cossu M, Andracco R, Santaniello A, Marchini M, Severino A, Caronni M, et al. Serum levels of vascular dysfunction markers reflect disease severity and stage in systemic sclerosis patients. Rheumatology (Oxford). 2016;55:1112\u20136 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26989111.","journal-title":"Rheumatology (Oxford)"},{"key":"2989_CR11","unstructured":"Riccieri V, Stefanantoni K, Vasile M, Macr\u00ec V, Sciarra I, Iannace N, et al. Abnormal plasma levels of different angiogenic molecules are associated with different clinical manifestations in patients with systemic sclerosis. Clin Exp Rheumatol. 29:S46\u201352 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21586218."},{"key":"2989_CR12","doi-asserted-by":"publisher","first-page":"2737","DOI":"10.1002\/art.38098","volume":"65","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology\/European League against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65:2737\u201347 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24122180.","journal-title":"Arthritis Rheum"},{"key":"2989_CR13","first-page":"2359","volume":"69","author":"M Cossu","year":"2017","unstructured":"Cossu M, van Bon L, Preti C, Rossato M, Beretta L, Radstake TRDJ. Earliest Phase of Systemic Sclerosis Typified by Increased Levels of Inflammatory Proteins in the Serum. Arthritis Rheumatol (Hoboken, NJ). [Internet]. 2017;69:2359\u201369 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/28859262.","journal-title":"[Internet]."},{"key":"2989_CR14","doi-asserted-by":"publisher","first-page":"2197","DOI":"10.1038\/s41467-020-15986-3","volume":"11","author":"S Stanley","year":"2020","unstructured":"Stanley S, Vanarsa K, Soliman S, Habazi D, Pedroza C, Gidley G, et al. Comprehensive aptamer-based screening identifies a spectrum of urinary biomarkers of lupus nephritis across ethnicities. Nat Commun. 2020;11:2197 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/32366845.","journal-title":"Nat Commun"},{"key":"2989_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/BF02595811","volume":"12","author":"Y Ge","year":"2003","unstructured":"Ge Y, Dudoit S, Speed TP. Resampling-based multiple testing for microarray data analysis. Test. 2003;12:1\u201377 Available from: http:\/\/link.springer.com\/10.1007\/BF02595811.","journal-title":"Test"},{"key":"2989_CR16","first-page":"2825","volume":"12","author":"F Pedregosa","year":"2011","unstructured":"Pedregosa F, Varoquaux G, Gramfort A, Michel V. Scikit-learn: Machine Learning in Python. J Mach Learn Res. 2011;12:2825\u201330.","journal-title":"J Mach Learn Res."},{"key":"2989_CR17","unstructured":"ShiniGO web application [Internet]. [cited 2022 May 19]. Available from: http:\/\/bioinformatics.sdstate.edu\/go\/"},{"key":"2989_CR18","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2020","unstructured":"Ge SX, Jung D, Yao R. ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics [Internet]. 2020;36:2628\u20139 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31882993.","journal-title":"Bioinformatics [Internet]."},{"key":"2989_CR19","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1093\/biomet\/92.3.619","volume":"92","author":"T Cai","year":"2005","unstructured":"Cai T, Tian L, Wei LJ. Semiparametric Box: Cox Power Transformation Models for Censored Survival Observations. Biometrika. 2005;92:619\u201332.","journal-title":"Biometrika."},{"key":"2989_CR20","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/S0167-9473(98)00096-6","volume":"30","author":"C Contal","year":"1999","unstructured":"Contal C, O\u2019Quigley J. An application of changepoint methods in studying the effect of age on survival in breast cancer. Comput Stat Data Anal [Internet]. 1999;30:253\u201370 Available from: https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167947398000966.","journal-title":"Comput Stat Data Anal [Internet]."},{"key":"2989_CR21","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.2517-6161.1976.tb01597.x","volume":"38","author":"BW Turnbull","year":"1976","unstructured":"Turnbull BW. The Empirical Distribution Function with Arbitrarily Grouped, Censored and Truncated Data. J R Stat Soc Ser B (Methodological). 1976;38:290\u20135.","journal-title":"J R Stat Soc Ser B (Methodological)"},{"key":"2989_CR22","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1002\/(SICI)1097-0258(19960715)15:13<1387::AID-SIM268>3.0.CO;2-R","volume":"15","author":"J Sun","year":"1996","unstructured":"Sun J. A non-parametric test for interval-censored failure time data with application to AIDS studies. Stat Med [Internet]. 1996;15:1387\u201395 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/8841649.","journal-title":"Stat Med [Internet]."},{"issue":"Suppl 3","key":"2989_CR23","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12911-016-0318-z","volume":"16","author":"L Beretta","year":"2016","unstructured":"Beretta L, Santaniello A. Nearest neighbor imputation algorithms: a critical evaluation. BMC Med Inform Decis Mak. 2016;16(Suppl 3):74 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27454392.","journal-title":"BMC Med Inform Decis Mak"},{"key":"2989_CR24","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1080\/03610918.2014.957839","volume":"46","author":"\u00d6 Asar","year":"2017","unstructured":"Asar \u00d6, Ilk O, Dag O. Estimating Box-Cox power transformation parameter via goodness-of-fit tests. Commun Stat Simul Comput [Internet]. 2017;46:91\u2013105. https:\/\/doi.org\/10.1080\/03610918.2014.957839.","journal-title":"Commun Stat Simul Comput [Internet]."},{"key":"2989_CR25","doi-asserted-by":"crossref","unstructured":"Anderson-Bergman C. icenReg\u00a0: Regression Models for Interval Censored Data in R. J Stat Softw [Internet]. 2017:81 Available from: http:\/\/www.jstatsoft.org\/v81\/i12\/.","DOI":"10.18637\/jss.v081.i12"},{"key":"2989_CR26","doi-asserted-by":"crossref","unstructured":"Fay MP, Shaw PA. Exact and Asymptotic Weighted Logrank Tests for Interval Censored Data: The interval R package. J Stat Softw [Internet]. 2010:36 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25285054.","DOI":"10.18637\/jss.v036.i02"},{"key":"2989_CR27","volume-title":"Miscellaneous Functions for Survival Data","author":"C Dardis","year":"2022","unstructured":"Dardis C. Miscellaneous Functions for Survival Data; 2022."},{"key":"2989_CR28","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.clim.2016.09.004","volume":"173","author":"M Cossu","year":"2016","unstructured":"Cossu M, van Bon L, Nierkens S, Bellocchi C, Santaniello A, Dolstra H, et al. The magnitude of cytokine production by stimulated CD56+ cells is associated with early stages of systemic sclerosis. Clin Immunol. 2016;173:76\u201380 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27616458.","journal-title":"Clin Immunol"},{"key":"2989_CR29","doi-asserted-by":"publisher","first-page":"1567","DOI":"10.1136\/annrheumdis-2015-207392","volume":"75","author":"Z Brkic","year":"2016","unstructured":"Brkic Z, van Bon L, Cossu M, van Helden-Meeuwsen CG, Vonk MC, Knaapen H, et al. The interferon type I signature is present in systemic sclerosis before overt fibrosis and might contribute to its pathogenesis through high BAFF gene expression and high collagen synthesis. Ann Rheum Dis [Internet]. 2016;75:1567\u201373 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26371289.","journal-title":"Ann Rheum Dis [Internet]."},{"key":"2989_CR30","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1007\/s10238-016-0437-y","volume":"17","author":"G Valentini","year":"2017","unstructured":"Valentini G, Riccardi A, Vettori S, Irace R, Iudici M, Tolone S, et al. CXCL4 in undifferentiated connective tissue disease at risk for systemic sclerosis (SSc) (previously referred to as very early SSc). Clin Exp Med [Internet]. 2017;17:411\u20134 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27650429.","journal-title":"Clin Exp Med [Internet]."},{"key":"2989_CR31","doi-asserted-by":"crossref","unstructured":"Chouri E, Wang M, Hillen MR, Angiolilli C, Silva-Cardoso SC, Wichers CGK, et al. Implication of miR-126 and miR-139-5p in Plasmacytoid Dendritic Cell Dysregulation in Systemic Sclerosis. J Clin Med [Internet]. 2021:10 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/33573268.","DOI":"10.3390\/jcm10030491"},{"key":"2989_CR32","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1056\/NEJMoa1114576","volume":"370","author":"L van Bon","year":"2014","unstructured":"van Bon L, Affandi AJ, Broen J, Christmann RB, Marijnissen RJ, Stawski L, et al. Proteome-wide analysis and CXCL4 as a biomarker in systemic sclerosis. N Engl J Med [Internet]. 2014;370:433\u201343 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24350901.","journal-title":"N Engl J Med [Internet]."},{"key":"2989_CR33","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fimmu.2019.00100","volume":"10","author":"B Mariotti","year":"2019","unstructured":"Mariotti B, Servaas NH, Rossato M, Tamassia N, Cassatella MA, Cossu M, et al. The Long Non-coding RNA NRIR Drives IFN-Response in Monocytes: Implication for Systemic Sclerosis. Front Immunol [Internet]. 2019;10:100 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/30804934.","journal-title":"Front Immunol [Internet]."},{"key":"2989_CR34","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1007\/s00281-015-0505-5","volume":"37","author":"Y Asano","year":"2015","unstructured":"Asano Y, Sato S. Vasculopathy in scleroderma. Semin Immunopathol [Internet]. 2015;37:489\u2013500 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26152638.","journal-title":"Semin Immunopathol [Internet]."},{"key":"2989_CR35","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.1002\/art.24038","volume":"58","author":"M Koenig","year":"2008","unstructured":"Koenig M, Joyal F, Fritzler MJ, Roussin A, Abrahamowicz M, Boire G, et al. Autoantibodies and microvascular damage are independent predictive factors for the progression of Raynaud\u2019s phenomenon to systemic sclerosis: a twenty-year prospective study of 586 patients, with validation of proposed criteria for early systemic sclerosi. Arthritis Rheum [Internet]. 2008;58:3902\u201312 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19035499.","journal-title":"Arthritis Rheum [Internet]."},{"key":"2989_CR36","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1093\/rheumatology\/keq176","volume":"50","author":"G Valentini","year":"2011","unstructured":"Valentini G, Cuomo G, Abignano G, Petrillo A, Vettori S, Capasso A, et al. Early systemic sclerosis: assessment of clinical and pre-clinical organ involvement in patients with different disease features. Rheumatology (Oxford) [Internet]. 2011;50:317\u201323 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/20562195.","journal-title":"Rheumatology (Oxford) [Internet]."},{"key":"2989_CR37","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/1529-0131(200004)43:4<889::AID-ANR21>3.0.CO;2-5","volume":"43","author":"M Hebbar","year":"2000","unstructured":"Hebbar M, Peyrat JP, Hornez L, Hatron PY, Hachulla E, Devulder B. Increased concentrations of the circulating angiogenesis inhibitor endostatin in patients with systemic sclerosis. Arthritis Rheum [Internet]. 2000;43:889\u201393 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10765935.","journal-title":"Arthritis Rheum [Internet]."},{"key":"2989_CR38","doi-asserted-by":"publisher","first-page":"576","DOI":"10.3899\/jrheum.080516","volume":"36","author":"LK Hummers","year":"2009","unstructured":"Hummers LK, Hall A, Wigley FM, Simons M. Abnormalities in the regulators of angiogenesis in patients with scleroderma. J Rheumatol [Internet]. 2009;36:576\u201382 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19228661.","journal-title":"J Rheumatol [Internet]."},{"key":"2989_CR39","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/S0092-8674(00)81848-6","volume":"88","author":"MS O\u2019Reilly","year":"1997","unstructured":"O\u2019Reilly MS, Boehm T, Shing Y, Fukai N, Vasios G, Lane WS, et al. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell [Internet]. 1997;88:277\u201385 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9008168.","journal-title":"Cell [Internet]."},{"key":"2989_CR40","first-page":"468","volume":"7","author":"M Li","year":"2021","unstructured":"Li M, Popovic Z, Chu C, Kr\u00e4mer BK, Hocher B. Endostatin in Renal and Cardiovascular Diseases. Kidney Dis (Basel, Switzerland). 2021;7:468\u201381 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/34901193.","journal-title":"Kidney Dis (Basel, Switzerland)"},{"key":"2989_CR41","first-page":"298239","volume":"2014","author":"J Golledge","year":"2014","unstructured":"Golledge J, Clancy P, Hankey GJ, Yeap BB, Norman PE. Serum endostatin concentrations are higher in men with symptoms of intermittent claudication. Dis Markers [Internet]. 2014;2014:298239 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24600079.","journal-title":"Dis Markers [Internet]."},{"key":"2989_CR42","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00418-006-0158-5","volume":"125","author":"R Paddenberg","year":"2006","unstructured":"Paddenberg R, Faulhammer P, Goldenberg A, Kummer W. Hypoxia-induced increase of endostatin in murine aorta and lung. Histochem Cell Biol [Internet]. 2006;125:497\u2013508 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/16465514.","journal-title":"Histochem Cell Biol [Internet]."},{"key":"2989_CR43","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s00395-009-0013-7","volume":"104","author":"A Lauten","year":"2009","unstructured":"Lauten A, Majos E, M\u00fchlich A, Wahlers T, Weider S, Fischer JH, et al. Ischemia-reperfusion injury activates early extracellular matrix processing and expression of endostatin in the heart with differential effects of temperature. Basic Res Cardiol [Internet]. 2009;104:559\u201369 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/19255800.","journal-title":"Basic Res Cardiol [Internet]."},{"key":"2989_CR44","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1111\/j.1440-1797.2007.00850.x","volume":"12","author":"MH Bellini","year":"2007","unstructured":"Bellini MH, Coutinho EL, Filgueiras TC, Maciel TT, Schor N. Endostatin expression in the murine model of ischaemia\/reperfusion-induced acute renal failure. Nephrology (Carlton) [Internet]. 2007;12:459\u201365 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17803469.","journal-title":"Nephrology (Carlton) [Internet]."},{"key":"2989_CR45","first-page":"136ra71","volume":"4","author":"Y Yamaguchi","year":"2012","unstructured":"Yamaguchi Y, Takihara T, Chambers RA, Veraldi KL, Larregina AT, Feghali-Bostwick CA. A peptide derived from endostatin ameliorates organ fibrosis. Sci Transl Med [Internet]. 2012;4:136ra71 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22649092.","journal-title":"Sci Transl Med [Internet]."},{"key":"2989_CR46","first-page":"90","volume":"24","author":"Y Ichiki","year":"1997","unstructured":"Ichiki Y, Smith EA, LeRoy EC, Trojanowska M. Basic fibroblast growth factor inhibits basal and transforming growth factor-beta induced collagen alpha 2(I) gene expression in scleroderma and normal fibroblasts. J Rheumatol [Internet]. 1997;24:90\u20135 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/9002017.","journal-title":"J Rheumatol [Internet]."},{"key":"2989_CR47","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1097\/MOH.0b013e3282f97d98","volume":"15","author":"M Murakami","year":"2008","unstructured":"Murakami M, Simons M. Fibroblast growth factor regulation of neovascularization. Curr Opin Hematol [Internet]. 2008;15:215\u201320 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18391788.","journal-title":"Curr Opin Hematol [Internet]."},{"key":"2989_CR48","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0014-5793(03)00003-6","volume":"536","author":"K Eriksson","year":"2003","unstructured":"Eriksson K, Magnusson P, Dixelius J, Claesson-Welsh L, Cross MJ. Angiostatin and endostatin inhibit endothelial cell migration in response to FGF and VEGF without interfering with specific intracellular signal transduction pathways. FEBS Lett [Internet]. 2003;536:19\u201324 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12586331.","journal-title":"FEBS Lett [Internet]."},{"key":"2989_CR49","doi-asserted-by":"publisher","first-page":"4606","DOI":"10.1073\/pnas.92.10.4606","volume":"92","author":"K Kuwabara","year":"1995","unstructured":"Kuwabara K, Ogawa S, Matsumoto M, Koga S, Clauss M, Pinsky DJ, et al. Hypoxia-mediated induction of acidic\/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells. Proc Natl Acad Sci U S A [Internet]. 1995;92:4606\u201310 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/7538678.","journal-title":"Proc Natl Acad Sci U S A [Internet]."},{"key":"2989_CR50","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10067-016-3483-7","volume":"36","author":"U \u0130lgen","year":"2017","unstructured":"\u0130lgen U, Yayla ME, D\u00fczg\u00fcn N. Low serum fibroblast growth factor 2 levels not accompanied by increased serum pentraxin 3 levels in patients with systemic sclerosis. Clin Rheumatol [Internet]. 2017;36:367\u201372 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/27878407.","journal-title":"Clin Rheumatol [Internet]."},{"key":"2989_CR51","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/B978-0-12-394307-1.00003-5","volume":"296","author":"Z Lokmic","year":"2012","unstructured":"Lokmic Z, Musyoka J, Hewitson TD, Darby IA. Hypoxia and hypoxia signaling in tissue repair and fibrosis. Int Rev Cell Mol Biol [Internet]. 2012;296:139\u201385 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/22559939.","journal-title":"Int Rev Cell Mol Biol [Internet]."},{"key":"2989_CR52","doi-asserted-by":"publisher","first-page":"10269","DOI":"10.1038\/s41598-019-46439-7","volume":"9","author":"Y-L Kuo","year":"2019","unstructured":"Kuo Y-L, Jou I-M, Jeng S-F, Chu C-H, Huang J-S, Hsu T-I, et al. Hypoxia-induced epithelial-mesenchymal transition and fibrosis for the development of breast capsular contracture. Sci Rep [Internet]. 2019;9:10269 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31311941.","journal-title":"Sci Rep [Internet]."},{"key":"2989_CR53","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.bbalip.2006.06.017","volume":"1761","author":"K Karasawa","year":"2006","unstructured":"Karasawa K. Clinical aspects of plasma platelet-activating factor-acetylhydrolase. Biochim Biophys Acta [Internet]. 2006;1761:1359\u201372 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/17049457.","journal-title":"Biochim Biophys Acta [Internet]."},{"key":"2989_CR54","doi-asserted-by":"crossref","unstructured":"Lordan R, Tsoupras A, Zabetakis I, Demopoulos CA. Forty Years Since the Structural Elucidation of Platelet-Activating Factor (PAF): Historical, Current, and Future Research Perspectives. Molecules [Internet]. 2019:24 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31816871.","DOI":"10.3390\/molecules24234414"},{"key":"2989_CR55","first-page":"II365","volume":"100","author":"EN Morgan","year":"1999","unstructured":"Morgan EN, Boyle EM, Yun W, Kovacich JC, Canty TG, Chi E, et al. Platelet-activating factor acetylhydrolase prevents myocardial ischemia-reperfusion injury. Circulation [Internet]. 1999;100:II365\u20138 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/10567331.","journal-title":"Circulation [Internet]."},{"key":"2989_CR56","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1042\/BSR20100128","volume":"31","author":"S Maerz","year":"2011","unstructured":"Maerz S, Liu C-H, Guo W, Zhu Y-Z. Anti-ischaemic effects of bilobalide on neonatal rat cardiomyocytes and the involvement of the platelet-activating factor receptor. Biosci Rep [Internet]. 2011;31:439\u201347 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21391918.","journal-title":"Biosci Rep [Internet]."},{"key":"2989_CR57","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1093\/rheumatology\/kez374","volume":"59","author":"A Sulli","year":"2020","unstructured":"Sulli A, Paolino S, Pizzorni C, Ferrari G, Pacini G, Pesce G, et al. Progression of nailfold capillaroscopic patterns and correlation with organ involvement in systemic sclerosis: a 12 year study. Rheumatology (Oxford) [Internet]. 2020;59:1051\u20138 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/31750929.","journal-title":"Rheumatology (Oxford) [Internet]."},{"key":"2989_CR58","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2174\/157339710904140417125010","volume":"9","author":"M Cutolo","year":"2013","unstructured":"Cutolo M, Pizzorni C, Sulli A, Smith V. Early Diagnostic and Predictive Value of Capillaroscopy in Systemic Sclerosis. Curr Rheumatol Rev [Internet]. 2013;9:249\u201353 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26932289.","journal-title":"Curr Rheumatol Rev [Internet]."},{"key":"2989_CR59","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1093\/rheumatology\/keu381","volume":"54","author":"B Vigone","year":"2015","unstructured":"Vigone B, Santaniello A, Marchini M, Montanelli G, Caronni M, Severino A, et al. Role of class II human leucocyte antigens in the progression from early to definite systemic sclerosis. Rheumatology (Oxford) [Internet]. 2015;54:707\u201311 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/25231181.","journal-title":"Rheumatology (Oxford) [Internet]."},{"key":"2989_CR60","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1751-0473-3-15","volume":"3","author":"A Camargo","year":"2008","unstructured":"Camargo A, Azuaje F, Wang H, Zheng H. Permutation - based statistical tests for multiple hypotheses. Source Code Biol Med [Internet]. 2008;3:15 Available from: http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/18939983.","journal-title":"Source Code Biol Med [Internet]."}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-023-02989-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-023-02989-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-023-02989-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,13]],"date-time":"2024-10-13T04:32:34Z","timestamp":1728793954000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-023-02989-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,27]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2989"],"URL":"https:\/\/doi.org\/10.1186\/s13075-023-02989-w","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,27]]},"assertion":[{"value":"11 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The present study involved human participants and was reviewed and approved by Comitato Etico Milano Area 2. The patients\/participants provided their written informed consent to participate in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"15"}}